ACAD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Tenax Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Clinical Development ADPT Q1 2026 Earnings EPS Beat Driven by Cost Discipline and Operational Progress RHP Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise but Stock Slips 08 ACTU Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Goldman Sachs Edges Higher GS Tests Key Resistance Near 1000 Level General American Investors GAM Posts Modest Gain Holds Near Resistance Esperion Therapeutics ESPR Holds Steady Amid Key Support and Resistance Levels SouthState Bank Corporation SSB Rises Modestly as Shares Hold Above Support MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns